|
Akorn, Inc. is a specialty pharmaceutical company engaged in the development, manufacturing and marketing of branded and multi-source pharmaceutical products. As a specialty pharmaceutical company, Akorn is focused on three major business segments: Ophthalmology, Hospitals, and Contract Manufacturing. With a historical revenue base of over $50 million, Akorn's eye is on the future. With numerous new product introductions planned in
2008 and 2009, Akorn is poised for tremendous growth.
Please feel free to contact us at investor.relations@akorn.com for any questions or further information. |
Investors Home
Stock Information
| symbol |
AKRX |
|
open |
1.15 |
|
change |
-0.05 |
| last price |
1.13 |
high |
1.165 |
time |
4:00pm |
| date |
7/2/2009 |
low |
0.92 |
volume |
1635783 |

Shareholder Information
Listed Security:
AKRX Common Stock
Exchange:
Nasdaq Global Market
Transfer Agent: Computershare Investor Services
Phone: 312-588-4640
Corporate Counsel: Luce, Forward, Hamilton & Scripps, LLP
Independent Accountants: Ernst & Young LLP
|